Entity Common Stock, Shares Outstanding of BioCrude Technologies USA, Inc. from 11 Sep 2017 to 12 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BioCrude Technologies USA, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 11 Sep 2017 to 12 Nov 2025.
  • BioCrude Technologies USA, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Nov 2025 was 50,854,726, a 0.01% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BioCrude Technologies USA, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 50,854,726 +4,070 +0.01% 12 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 50,854,726 +4,070 +0.01% 14 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 50,854,726 +30,665 +0.06% 15 Mar 2025 10-K 27 Mar 2025 2024 FY
Q3 2024 50,850,656 +49,895 +0.1% 07 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 50,850,656 +52,895 +0.1% 09 Aug 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 50,824,061 +56,800 +0.11% 29 Mar 2024 10-K 27 Mar 2024 2023 FY
Q3 2023 50,800,761 +55,625 +0.11% 13 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 50,797,761 +74,875 +0.15% 10 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 50,767,261 +44,375 +0.09% 29 Mar 2023 10-K 29 Mar 2023 2022 FY
Q3 2022 50,745,136 +34,750 +0.07% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 50,722,886 +12,500 +0.02% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 50,722,886 +42,500 +0.08% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 50,710,386 +89,050 +0.18% 31 Dec 2021 10-K 23 Mar 2022 2022 FY
Q3 2021 50,710,386 +163,050 +0.32% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 50,710,386 +211,550 +0.42% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 50,680,386 +186,550 +0.37% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 50,621,336 +137,500 +0.27% 31 Dec 2020 10-K 12 Feb 2021 2020 FY
Q3 2020 50,547,336 +63,500 +0.13% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 50,498,836 +68,096 +0.14% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 50,493,836 +63,494 +0.13% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 50,483,836 +53,494 +0.11% 31 Dec 2019 10-K 20 Mar 2020 2019 FY
Q3 2019 50,483,836 +58,829 +0.12% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 50,430,740 +8,733 +0.02% 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 50,430,342 +14,396 +0.03% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 50,430,342 +375,699 +0.75% 31 Dec 2018 10-K 17 Apr 2019 2018 FY
Q3 2018 50,425,007 +485,448 +0.97% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 50,422,007 30 Jun 2018 10-Q 24 Aug 2018 2018 Q2
Q1 2018 50,415,946 31 Mar 2018 10-Q 16 May 2018 2018 Q1
Q4 2017 50,054,643 31 Dec 2017 10-K/A 02 Nov 2018 2017 FY
Q3 2017 49,939,559 11 Sep 2017 10-Q 12 Sep 2017 2017 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.